By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …

Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

Abstract Supplementary Table S1 Continuous Glucose Monitoring (CGM) has been
demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia …

By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Background The threshold-suspend feature of sensor-augmented insulin pumps is designed
to minimize the risk of hypoglycemia by interrupting insulin delivery at a preset sensor …

Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …

Importance Hypoglycemia is a critical obstacle to the care of patients with type 1 diabetes.
Sensor-augmented insulin pump with automated low-glucose insulin suspension has the …

Pursuit of a closed-loop artificial pancreas that automatically controls the blood glucose of
individuals with type 1 diabetes has intensified during the past 6years. Here we discuss the …

Background: The efficacy of automatic suspension of insulin delivery in induced
hypoglycemia among subjects with type 1 diabetes was evaluated. Subjects and Methods …